| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 07/05/2024 | 15:18 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:PAVMZ | PAVmed Inc |
| 17/01/2023 | 22:05 | Business Wire | PAVmed and Lucid Diagnostics Provide Strategic Business Update | NASDAQ:PAVMZ | PAVmed Inc |
| 11/01/2023 | 14:00 | Business Wire | PAVmed and Lucid Diagnostics to Provide Strategic Business Update | NASDAQ:PAVMZ | PAVmed Inc |
| 22/12/2022 | 14:25 | Business Wire | PAVmed Partners with Novosound on Ultrasound Imaging Technology | NASDAQ:PAVMZ | PAVmed Inc |
| 15/12/2022 | 14:25 | Business Wire | PAVmed Digital Health Subsidiary Veris Health Launches Veris Cancer Care Platform | NASDAQ:PAVMZ | PAVmed Inc |
| 08/12/2022 | 14:25 | Business Wire | Lucid Diagnostics Selected as Finalist for Medtech Company of the Year 2022 by Medical Device + Diagnostic Industry | NASDAQ:PAVMZ | PAVmed Inc |
| 01/12/2022 | 14:25 | Business Wire | Lucid Diagnostics Presents Real-World EsoCheck Data at the American Association for Cancer Research | NASDAQ:PAVMZ | PAVmed Inc |
| 14/11/2022 | 22:40 | Business Wire | Lucid Diagnostics Provides Business Update and Third Quarter 2022 Financial Results | NASDAQ:PAVMZ | PAVmed Inc |
| 11/11/2022 | 14:25 | Business Wire | PAVmed to Participate in BTIG Digital Health Forum | NASDAQ:PAVMZ | PAVmed Inc |
| 10/11/2022 | 14:25 | Business Wire | Lucid Diagnostics to Participate in Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum | NASDAQ:PAVMZ | PAVmed Inc |
| 09/11/2022 | 14:25 | Business Wire | Lucid Diagnostics Commences Production of EsoCheck Devices with High-Volume Manufacturer | NASDAQ:PAVMZ | PAVmed Inc |
| 03/11/2022 | 13:25 | Business Wire | PAVmed to Hold a Business Update Conference Call and Webcast on November 15, 2022 | NASDAQ:PAVMZ | PAVmed Inc |
| 02/11/2022 | 13:25 | Business Wire | Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 14, 2022 | NASDAQ:PAVMZ | PAVmed Inc |
| 30/08/2022 | 14:25 | Business Wire | PAVmed to Participate in the Lake Street 6th Annual Best Ideas Growth Conference and the A.G.P. Virtual MedTech Conference | NASDAQ:PAVMZ | PAVmed Inc |
| 16/08/2022 | 22:40 | Business Wire | PAVmed Provides Business Update and Preliminary Second Quarter 2022 Financial Results | NASDAQ:PAVMZ | PAVmed Inc |
| 11/08/2022 | 14:25 | Business Wire | Lucid Diagnostics Launches Stage II Lucid Test Center Expansion in California, Texas, Florida, and Ohio | NASDAQ:PAVMZ | PAVmed Inc |
| 04/08/2022 | 14:25 | Business Wire | Newly Published American Gastroenterological Association Clinical Practice Update Supports Esophageal Precancer Screening Using Lucid Diagnostics’ EsoGuard® and EsoCheck® Technologies | NASDAQ:PAVMZ | PAVmed Inc |
| 19/07/2022 | 14:25 | Business Wire | PAVmed Chairman & CEO Lishan Aklog, M.D. Named to Savoy’s 2022 Most Influential Black Executives in Corporate America | NASDAQ:PAVMZ | PAVmed Inc |
| 18/07/2022 | 14:25 | Business Wire | Lucid Diagnostics to Participate in the Canaccord 42nd Annual Growth Conference and the 7th Annual Needham Med Tech & Diagnostics 1x1 Conference | NASDAQ:PAVMZ | PAVmed Inc |
| 13/05/2022 | 14:25 | Business Wire | PAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. Named Top 50 Healthcare Technology CEO | NASDAQ:PAVMZ | PAVmed Inc |
| 28/04/2022 | 22:05 | GlobeNewswire Inc. | PAVmed Announces Procedural Update on its Settlement of a Previously Disclosed Class Action Lawsuit | NASDAQ:PAVMZ | PAVmed Inc |
| 26/04/2022 | 14:25 | Business Wire | PAVmed to Hold a Business Update Conference Call on May 12, 2022 | NASDAQ:PAVMZ | PAVmed Inc |
| 29/03/2022 | 22:11 | Business Wire | PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results | NASDAQ:PAVMZ | PAVmed Inc |
| 23/03/2022 | 13:25 | Business Wire | PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers | NASDAQ:PAVMZ | PAVmed Inc |
| 17/03/2022 | 13:25 | Business Wire | PAVmed Announces Successful First-in-Human Implantations of its PortIO™ Intraosseous Infusion System | NASDAQ:PAVMZ | PAVmed Inc |
| 10/03/2022 | 14:25 | Business Wire | PAVmed Subsidiary Veris Health Launches World-Class Technology Advisory Board | NASDAQ:PAVMZ | PAVmed Inc |
| 08/03/2022 | 14:30 | Business Wire | PAVmed to Hold a Business Update Conference Call on March 29, 2022 | NASDAQ:PAVMZ | PAVmed Inc |
| 07/03/2022 | 14:30 | Business Wire | Lucid Diagnostics to Hold a Business Update Conference Call on March 28, 2022 | NASDAQ:PAVMZ | PAVmed Inc |
| 04/03/2022 | 14:25 | Business Wire | Lucid Diagnostics to Participate in the LSI USA ’22 Emerging Medtech Summit | NASDAQ:PAVMZ | PAVmed Inc |
| 03/03/2022 | 14:25 | Business Wire | PAVmed Subsidiary Lucid Diagnostics Launches LucidDx Labs to Accommodate EsoGuard Testing Growth | NASDAQ:PAVMZ | PAVmed Inc |